Aethon Therapeutics
About Aethon Therapeutics
The startup develops a cancer immunotherapy platform that designs neoantigens to enhance targeted therapies against oncogenic driver mutations, including RAS and EGFR. This approach aims to effectively eliminate residual cancer cells, including drug-resistant persister cells, improving treatment outcomes for patients with cancer.
What does Aethon Therapeutics do?
The startup develops a cancer immunotherapy platform that designs neoantigens to enhance targeted therapies against oncogenic driver mutations, including RAS and EGFR. This approach aims to effectively eliminate residual cancer cells, including drug-resistant persister cells, improving treatment outcomes for patients with cancer.
Where is Aethon Therapeutics located?
Aethon Therapeutics is based in City of New York, United States.
When was Aethon Therapeutics founded?
Aethon Therapeutics was founded in 2022.
How much funding has Aethon Therapeutics raised?
Aethon Therapeutics has raised 30000000.
- Location
- City of New York, United States
- Founded
- 2022
- Funding
- 30000000
- Employees
- 14 employees